Dr. Daniel Tang
Advisory Board Member at Blue Ocean Capital Group
About
Dr. Daniel Tang joined the advisory board of BOCG in May 2024. He previously served as CEO of Shanghai NK CellTech and was founding CEO of Thororna Inc, a biotech company working on circular RNA technology, where he led three funding rounds raising over 430 million RMB. Earlier roles include COO of Phanes Therapeutics, CEO of UPP, GM for ICON Clinical Research in APAC, SVP at Frontage, VP at ChemPartner, and senior principal scientist positions at Pfizer and DuPont. He holds a BS in Biochemistry from Peking University, a PhD from George Washington University, and an MBA from the University of Michigan.
Invests in
Biotech
Colleagues at Blue Ocean Capital Group
Dr Waleed AI-Shaqha
Science & Strategic Advisor at Blue Ocean Capital Group
Dr. Duanqing Pei
Chief Scientist Advisor in Cell & Regenerative Medicine at Blue Ocean Capital Group
Dr. Haibo Qian
Senior Industry Advisor at Blue Ocean Capital Group
Dr. Hua Jiang
Senior Industry Advisor at Blue Ocean Capital Group
Dr. Jean Paul Thiery
Senior Advisor at Blue Ocean Capital Group
Dr. Jixi Li
Senior Advisor at Blue Ocean Capital Group
Dr. Min Zhuo
Chief Scientific Advisor for Neuroscience at Blue Ocean Capital Group
Dr. Xinye Xiao
Industry Advisor at Blue Ocean Capital Group